Low-dose interleukin-2 fosters a dose-dependent regulatory T cell tuned milieu in T1D patients
- 1 April 2015
- journal article
- research article
- Published by Elsevier in Journal of Autoimmunity
- Vol. 58, 48-58
Abstract
No abstract availableKeywords
Funding Information
- DRCD
- CIC-PE
- CIC-BTi
- Inserm
- National Institute of Allergy and Infectious Diseases
- Juvenile Diabetes Research Foundation
- Diabetes Research Institute Foundation
- Peacock Foundation, Inc.
- Anton E. B. Schefer Foundation
This publication has 66 references indexed in Scilit:
- Phenotypical and functional specialization of FOXP3+ regulatory T cellsNature Reviews Immunology, 2011
- Mechanisms of impaired regulation by CD4+CD25+FOXP3+ regulatory T cells in human autoimmune diseasesNature Reviews Immunology, 2010
- IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cellsJournal of Experimental Medicine, 2010
- Interleukin-2 Receptor Signaling: At the Interface between Tolerance and ImmunityImmunity, 2010
- Decrease of Foxp3+ Treg Cell Number and Acquisition of Effector Cell Phenotype during Lethal InfectionImmunity, 2009
- Cell-specific protein phenotypes for the autoimmune locus IL2RA using a genotype-selectable human bioresourceNature Genetics, 2009
- Central Role of Defective Interleukin-2 Production in the Triggering of Islet Autoimmune DestructionImmunity, 2008
- Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetesNature Genetics, 2007
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences, 2005
- PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetesNature Genetics, 2003